Fifty-five individuals have regained health after overcoming COVID-19.
Breaking News:
Over the past 24 hours, 55 individuals have successfully fought off COVID-19 in Kazakhstan, according to Almaty.tv.
Let's take a look at the recovery numbers by regions:
- Almaty city - 8
- Shymkent city - 14
- Atyrau region - 6
- East Kazakhstan region - 16
- Karaganda region - 3
- Kostanay region - 2
- Pavlodar region - 2
- Turkestan region - 4
These findings have been reported by coronavirus2020.kz, totaling 101,877 recoveries in Kazakhstan to date.
While there's no specific daily recovery rate for Kazakhstan or its regions, recent studies suggest:
- Impact on other health outcomes: COVID-19 disrupted TB management in Kazakhstan, with TB mortality climbing from 6% pre-pandemic to 9% during the pandemic, and adverse TB outcomes increasing from 11% to 20%[5].
- Treatment efficacy: Recommended COVID-19 treatments include Paxlovid (resulting in an 80% reduction in severe cases) and Remdesivir (leading to an 87% reduction in severe outcomes) when administered promptly[2].
- Economic recovery: There's been a rebound in Kazakhstan-Vietnam trade, hitting $1 billion in 2024 following the pandemic, evidence of broader economic recovery[4].
For more detailed and real-time recovery data, it's recommended to keep an eye on official reports from Kazakhstan's health ministry. This latest news focuses primarily on treatment protocols and comparative mortality trends, providing less granular daily recovery metrics for each region.
- A total of 101,877 individuals in Kazakhstan, as reported by coronavirus2020.kz, have recovered from the coronavirus2020 so far.
- In the city of Almaty, 8 individuals have recovered from the coronavirus2020, according to the recovery numbers by regions.
- The study suggests that COVID-19 has had an impact on other health outcomes, with TB mortality climbing from 6% pre-pandemic to 9% during the pandemic.
- Recommended COVID-19 treatments like Paxlovid and Remdesivir have shown promising results, with Paxlovid resulting in an 80% reduction in severe cases and Remdesivir leading to an 87% reduction in severe outcomes when administered promptly.
